Second primary malignancies after radioiodine therapy for differentiated thyroid carcinoma

被引：0
|
作者：
Macedo, R. [1 ]
Costa, G. [1 ]
Albuquerque, A. [1 ]
Pedroso de Lima, J. [1 ]
机构：
[1] Hosp Univ Coimbra, Coimbra, Portugal
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2008年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S343 / S343
页数：1
相关论文
共 50 条
  • [31] Second Primary Malignancies in Patients with Differentiated Thyroid Cancer after Radionuclide Therapy: A Retrospective Single-Centre Study
    Piscopo, Leandra
    Volpe, Fabio
    Nappi, Carmela
    Zampella, Emilia
    Manganelli, Mariarosaria
    Matrisciano, Francesca
    Totaro, Pasquale
    Pace, Leonardo
    Maurea, Simone
    Cuocolo, Alberto
    Klain, Michele
    CURRENT ONCOLOGY, 2023, 30 (01) : 37 - 44
  • [32] OUTCOME AFTER HIGH-DOSE RADIOIODINE THERAPY FOR ADVANCED DIFFERENTIATED THYROID CARCINOMA IN CHILDHOOD
    Gao, Yun-Chao
    Lu, Han-Kui
    ENDOCRINE RESEARCH, 2009, 34 (04) : 121 - 129
  • [33] TIME COURSE OF THYROGLOBULIN AUTOANTIBODIES IN PATIENTS WITH DIFFERENTIATED THYROID-CARCINOMA AFTER RADIOIODINE THERAPY
    MOSER, E
    BRAUN, S
    KIRSCH, CM
    KLEINHANS, E
    BUELL, U
    NUCLEAR MEDICINE COMMUNICATIONS, 1984, 5 (05) : 317 - 321
  • [34] Second primary malignancies after radioiodine in thyroid cancer patients and the association with radioiodine dosage: A nationwide population-based study
    Teng, C. J.
    Hu, Y. W.
    Liu, C. J.
    Chiang, H. L.
    Chen, T. J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S754 - S754
  • [35] Guidelines on radioiodine therapy for differentiated thyroid carcinoma -: Impact on clinical practice
    Biermann, M
    Pixberg, MK
    Dörr, U
    Dietlein, M
    Schlemmer, H
    Grimm, J
    Zajic, T
    Nestle, U
    Ladner, S
    Sepehr-Rezai, S
    Rosenbaum, S
    Puskás, C
    Fostitsch, P
    Heinecke, A
    Schuck, A
    Willich, N
    Schmid, KW
    Dralle, H
    Schober, O
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2005, 44 (06): : 229 - +
  • [36] ''High-dose'' radioiodine therapy in advanced differentiated thyroid carcinoma
    Menzel, C
    Grunwald, F
    Schomburg, A
    Palmedo, H
    Bender, H
    Spath, G
    Biersack, HJ
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (09) : 1496 - 1503
  • [37] RADIOIODINE THERAPY IN WELL-DIFFERENTIATED PAPILLARY AND FOLLICULAR CARCINOMA OF THYROID
    VARMA, VM
    REBA, RC
    JOURNAL OF NUCLEAR MEDICINE, 1978, 19 (06) : 714 - 715
  • [38] Second Primary Malignancy After Radioiodine Therapy in Thyroid Cancer Patient: A Nationwide Study
    Chae Moon Hong
    Junik Son
    Min Kyung Hyun
    Jang Won Lee
    Jaetae Lee
    Nuclear Medicine and Molecular Imaging, 2023, 57 : 275 - 286
  • [39] SOMATIC RISKS OF RADIOIODINE THERAPY IN PATIENTS WITH DIFFERENTIATED THYROID-CARCINOMA
    PUSKAS, C
    SCIUK, J
    SCHOBER, O
    NUKLEARMEDIZINER, 1990, 13 (05): : 295 - 304
  • [40] Editorial: Optimizing the outcomes of adjuvant radioiodine therapy in differentiated thyroid carcinoma
    Sherman, SI
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (09): : 4059 - 4062
12345